Long-acting formulations of insulin glargine
PK201100350A0Active Publication Date: 2011-05-27SANOFI AVENTIS SA
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100350
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-05-17
- Publication Date
- 2011-05-27
Abstract
The present invention relates to an aqueous pharmaceutical formulation comprising 300 U / mL [equimolar to 300IU human insulin] of insulin glargine and an analogue of exendin-4 selected from a group comprising lixisentatide, exenatide and liraglutide for use in the treatment of Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus.
Need to check novelty before this filing date? Find Prior Art